abetalol versus Enalapril for the management of postpartum hypertension-An open label randomized control trial

Internal Fluid Research0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Postnatal women with new onset hypertension( blood pressure >= 140 mm Hg systolic or >=90mmHg diastolic)
•Women who had been diagnosed with intrapartum hypertension, treated with single short acting antihypertensive , during postnatal monitoring found to have blood pressure >= 140 mm Hg systolic or >=90mmHg diastolic.
•Women who had been on single antihypertensive before pregnancy which was stopped postnatally and later detected to have hypertension after the wash out period of first drug.

•Women with severe intrapartum hypertension or gestational hypertension requiring >=1 antihypertensives.
•Women who were already on antihypertensive drugs antenatally and the same continued postnatally
•Women with creatinine >1.4 mg/dl
•Women with urine output <100 ml in 4 hours
•Women with known heart block, cardiac failure or heart rate <60 bpm
•Allergy to labetalol or enalapril
•Moderate, persistent or severe asthma
•Women with hyperkalemia

发起方

Internal Fluid Research